COVID-19,可能的肝通路和酒精滥用-我们到2023年知道什么?
Agata Michalak1, Tomasz Lach2, Karolina Szczygieł3
1Department of Gastroenterology with Endoscopy Unit, Medical University of Lublin, Jaczewskiego 8, 20-954 Lublin, Poland.
International journal of molecular sciences
|February 24, 2024
概括
COVID-19大流行严重影响了肝脏健康,影响了慢性肝病 (CLD) 和酒精性肝病 (ALD) 的患者. 了解SARS-CoV-2感染和肝脏疾病之间的相互作用对于患者的治疗结果至关重要.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 传染性疾病 传染性疾病
- 全球健康 全球健康
背景情况:
- 冠状病毒疾病2019 (COVID-19) 具有广泛的肺外影响,包括显著的肝脏表现.
- 慢性肝病 (CLD) 被认为是影响COVID-19患者预后的关键因素.
- SARS-CoV-2 影响肝脏的特定机制以及先前存在的肝脏疾病的作用仍然是积极调查的领域.
研究的目的:
- 阐明肝脏在COVID-19感染中的作用.
- 专门研究酒精性肝病 (ALD) 对COVID-19结果的影响.
- 分析涉及COVID-19的病理途径,乙醇毒性和肝硬化.
主要方法:
- 审查有关COVID-19和肝脏疾病的现有文献.
- 对有关SARS-CoV-2肝脏表现的临床数据和病例研究的分析.
- 在病毒感染的背景下对乙醇毒性和肝硬化病理生理学检查.
主要成果:
- COVID-19直接影响肝脏,而先前存在的肝脏疾病会使患者的结果恶化.
- 酒精性肝病 (ALD) 与SARS-CoV-2存在复杂的相互作用,乙醇毒性和肝硬化都会导致肝功能障碍.
- 在COVID-19相关的严重肝损伤中,ALD的确切因果或触发作用需要进一步澄清.
结论:
- 在COVID-19期间,肝脏是重要的目标器官,CLL和ALD具有相当大的风险.
- 需要进一步的研究来区分急性SARS-CoV-2肝损伤的影响与之前存在的肝病如ALD和肝硬化病的恶化.
- 了解这些相互作用对于开发针对脆弱患者群体的向治疗策略至关重要.
相关概念视频
Hepatic Drug Excretion: Influencing Factors
130
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
130
CNS Depressants: Alcohol and Nicotine
209
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
209
Hepatic Portal System
1.3K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
1.3K
Diseases of the Liver and Gallbladder
538
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
538
Hepatic Drug Clearance: Role of Transporters
59
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
59
Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance
119
Hepatic clearance refers to the volume of blood cleared of a drug by the liver per unit of time. It plays a crucial role in drug metabolism and elimination. While hepatic clearance is commonly estimated by subtracting renal clearance from total body clearance, other pathways, such as pulmonary or biliary clearance, may also contribute. However, these pathways are generally less significant than hepatic and renal clearance.
Most drugs undergo restrictive clearance, which is proportional to the...
Most drugs undergo restrictive clearance, which is proportional to the...
119


